IFN-γ treatment of tumor cells usually restores peptide supply to β2m-HLA HC complexes by up-regulating expression of APM components and reverses HLA class I down-regulation, that is particularly evident in NB cells (Seliger et al., 2000). Here, IFNG is linked to neuroblastoma.